Multiparametric Magnetic Resonance Imaging Improves the Prognostic Outcomes in Patients With Intrahepatic Cholangiocarcinoma After Curative-Intent Resection

Qian Li, Yi Wei, Feng Che, Tong Zhang, Shan Yao, Jian Zhao, Yuhui Zhang, Hehan Tang, Bin SongFrontiers in Oncology 2022 · DOI

TL;DR

This study demonstrates that adding multiparametric MRI (mpMRI) to standard CT scans for intrahepatic cholangiocarcinoma (ICC) patients significantly improves prognostic outcomes, including overall survival and recurrence-free survival. The enhanced imaging capabilities of mpMRI allow for the detection of more subtle tumor features, leading to more tailored and effective treatment strategies.

What Problem Does This Paper Address?

Intrahepatic cholangiocarcinoma (ICC) is a challenging liver cancer with a high recurrence rate after surgical resection, leading to poor survival outcomes. While contrast-enhanced computed tomography (CECT) is the standard imaging technique for diagnosis and surgical planning, it has limitations in detecting the full extent of the tumor, particularly subtle lesions, longitudinal spread along bile ducts, and small foci of invasion. This can lead to incomplete surgical resection and subsequent recurrence. The study aims to investigate whether incorporating multiparametric MRI (mpMRI) – which combines various MRI sequences like MRCP and DWI – can provide a more comprehensive assessment of ICC, guide better treatment decisions, and ultimately improve patient prognosis compared to CECT alone.

Methods

This retrospective study involved 287 patients diagnosed with ICC. The primary comparison was between two groups: a larger group of 256 patients who underwent CECT only (CT group) and a smaller group of 31 patients who received both CECT and mpMRI (CT+MR group). To account for potential selection bias and confounding factors due to the differing group sizes, the researchers employed propensity score matching (PSM) to create a balanced cohort of 31 matched pairs.

The imaging evaluation involved two independent radiologists for CT and two for MRI, all blinded to clinical data and outcomes. They assessed various imaging features, including tumor morphology, size, duct dilatation, capsular retraction, arterial phase enhancement patterns, multifocality, satellite nodules, tumor in vein, central necrosis, portal venous phase washout, and peritumoral parenchymal arterial phase hyperenhancement (APHE).

Pathological data, including tumor size, TNM staging, differentiation, lymph node metastasis, and microvascular invasion, were collected. Patient follow-up included serum tumor markers and imaging studies every 3-6 months. Overall survival (OS) and recurrence-free survival (RFS) were the primary endpoints, analyzed using Kaplan-Meier curves and Cox proportional hazard models.

Datasets

The study utilized retrospective data from 287 patients with intrahepatic cholangiocarcinoma (ICC) diagnosed between January 2009 and December 2017 at West China Hospital, Sichuan University. The data included clinical, imaging (CECT and mpMRI), and pathological information. No new datasets were introduced.

Key Insights and Ideas

  • mpMRI's Superiority in Detecting Subtle Lesions: mpMRI, particularly with its DWI sequences, proved significantly more sensitive than CECT in identifying additional occult lesions, larger tumor sizes, and peritumoral APHE. This suggests that CECT may underestimate the true extent of ICC.
  • Impact on Treatment Decisions: The additional information provided by mpMRI directly influenced treatment decisions. For instance, the detection of more nodules led to extended liver resections or radiofrequency ablation for additional lesions, while findings like biliary dilation prompted timely Roux-en-Y hepaticojejunostomy.
  • Prognostic Significance: The study strongly indicates that the improved detection and characterization of ICC by mpMRI translate into tangible survival benefits. Patients who received mpMRI showed significantly better OS and RFS, even after accounting for potential confounders through PSM.
  • Peritumoral APHE as a Key Indicator: The presence of peritumoral APHE, often missed by CECT, was highlighted as an important finding that can indicate the extent of tumor invasion and guide surgical planning for more comprehensive resection.

Key Results

  • Improved Survival: The CT+MRI group demonstrated significantly higher 1-, 3-, and 5-year OS rates (87.10%, 58.06%, 9.67%) compared to the CT-only group (66.80%, 24.61%, 4.30%). Similarly, RFS rates were also substantially better in the CT+MRI group.
  • Multivariable Analysis: In multivariable Cox proportional hazard models, the CT+MR group was an independent prognostic factor for a lower risk of mortality (OS: HR 0.396, 95% CI 0.239–0.657, p < 0.001) and recurrence (RFS: HR 0.558, 95% CI 0.352–0.882, p = 0.013).
  • Propensity Score Matching: After PSM, the CT+MRI group continued to show better prognostic outcomes (OS: HR 0.400, 95% CI 0.218–0.736, p = 0.003; RFS: HR 0.508, 95% CI 0.288–0.897, p = 0.020), reinforcing the findings.
  • Imaging Findings: mpMRI identified additional occult tumors in 6 patients, larger tumor sizes in 24 patients (p=0.041), peritumoral APHE in 18 patients (p<0.001), and biliary dilation in 4 patients (p=0.031) that were not as clearly depicted by CECT.

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Design and Single Institution: The retrospective nature and data from a single institution may introduce selection bias and limit generalizability. While PSM was used to mitigate bias, a prospective, multicenter study would be more robust.
  • Exclusion of Gadoxetic Acid-Enhanced MRI: The study did not include patients who underwent gadoxetic acid-enhanced MRI, which has shown promise in detecting small lesions (<2 cm) and improving prognostic outcomes.
  • CT Slice Thickness: The standard 5-mm CT slice thickness used might miss very small hepatic lesions. Future research could explore the impact of thinner CT slices (e.g., 1.2 mm) on assessment.

Future work should focus on prospective, multicenter studies, potentially incorporating gadoxetic acid-enhanced MRI and investigating the optimal CT slice thickness to further refine the diagnostic and prognostic value of imaging in ICC management.

Summary updated

Abstract

Additional mpMRI helps clinicians to select better treatment options, lower the risk of tumor recurrence, and improve the overall survival.
BibTeX
@inproceedings{li2022multiparametric,
  author = {Qian Li and Yi Wei and Feng Che and Tong Zhang and Shan Yao and Jian Zhao and Yuhui Zhang and Hehan Tang and Bin Song},
  title = {{Multiparametric Magnetic Resonance Imaging Improves the Prognostic Outcomes in Patients With Intrahepatic Cholangiocarcinoma After Curative-Intent Resection}},
  booktitle = {Frontiers in Oncology},
  year = {2022},
  doi = {10.3389/fonc.2022.756726},
}
Figure